| Daniel Joseph Hayes Jr, MD | |
|
830 Old Lancaster Rd, Suite 101, Bryn Mawr, PA 19010-3118 | |
| (610) 527-1185 | |
| Not Available |
| Full Name | Daniel Joseph Hayes Jr |
|---|---|
| Gender | Male |
| Speciality | Vascular Surgery |
| Experience | 20 Years |
| Location | 830 Old Lancaster Rd, Bryn Mawr, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1447454301 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2086S0129X | Surgery - Vascular Surgery | MD435940 (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Penn Medicine Home Health | Bala cynwyd, PA | Home health agency |
| Chester County Hospital | West chester, PA | Hospital |
| Bryn Mawr Hospital | Bryn mawr, PA | Hospital |
| Paoli Hospital | Paoli, PA | Hospital |
| Riddle Memorial Hospital | Media, PA | Hospital |
| Main Line Hospital Lankenau | Wynnewood, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Prospect Health Access Network Inc | 5698065142 | 196 |
| Vascular Surgical Specialists Pllc | 8123386703 | 7 |
News Archive
Cellectis bioresearch, a specialist in genome customization and a subsidiary of Cellectis, today announced the publication of a scientific study describing a novel method, based on meganuclease-driven targeted integration, for the generation of stable cell lines compatible with high throughput screening (HTS).The study demonstrated Cellectis bioresearch's technology to be faster, more reliable and efficient in deriving cell-based assays for HTS studies than classical methods.
A causative gene for a highly common type of hearing loss (sensorineural hearing loss, or SNHL) has been identified by a group of Japanese researchers, who successfully replicated the condition using a transgenic mouse.
Researchers from the Toronto Western Research Institute noted a higher prevalence of arthritis and arthritis-attributable activity limitations (AAL) in the U.S. versus the Canadian population. The authors attribute the higher prevalence of arthritis and AAL to a greater level of obesity and physical inactivity in Americans, particularly women.
In an encouraging development, an investigational vaccine regimen has been shown to be well-tolerated and to have a modest effect in preventing HIV infection in a clinical trial involving more than 16,000 adult participants in Thailand. Following a final analysis of the trial data, the Surgeon General of the U.S. Army, the trial sponsor, announced today that the prime-boost investigational vaccine regimen was safe and 31 percent effective in preventing HIV infection.
› Verified 7 days ago
| Entity Name | Prospect Health Access Network Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1568819084 PECOS PAC ID: 5698065142 Enrollment ID: O20160613000737 |
News Archive
Cellectis bioresearch, a specialist in genome customization and a subsidiary of Cellectis, today announced the publication of a scientific study describing a novel method, based on meganuclease-driven targeted integration, for the generation of stable cell lines compatible with high throughput screening (HTS).The study demonstrated Cellectis bioresearch's technology to be faster, more reliable and efficient in deriving cell-based assays for HTS studies than classical methods.
A causative gene for a highly common type of hearing loss (sensorineural hearing loss, or SNHL) has been identified by a group of Japanese researchers, who successfully replicated the condition using a transgenic mouse.
Researchers from the Toronto Western Research Institute noted a higher prevalence of arthritis and arthritis-attributable activity limitations (AAL) in the U.S. versus the Canadian population. The authors attribute the higher prevalence of arthritis and AAL to a greater level of obesity and physical inactivity in Americans, particularly women.
In an encouraging development, an investigational vaccine regimen has been shown to be well-tolerated and to have a modest effect in preventing HIV infection in a clinical trial involving more than 16,000 adult participants in Thailand. Following a final analysis of the trial data, the Surgeon General of the U.S. Army, the trial sponsor, announced today that the prime-boost investigational vaccine regimen was safe and 31 percent effective in preventing HIV infection.
› Verified 7 days ago
| Entity Name | Vascular Surgical Specialists Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1932610755 PECOS PAC ID: 8123386703 Enrollment ID: O20180103002979 |
News Archive
Cellectis bioresearch, a specialist in genome customization and a subsidiary of Cellectis, today announced the publication of a scientific study describing a novel method, based on meganuclease-driven targeted integration, for the generation of stable cell lines compatible with high throughput screening (HTS).The study demonstrated Cellectis bioresearch's technology to be faster, more reliable and efficient in deriving cell-based assays for HTS studies than classical methods.
A causative gene for a highly common type of hearing loss (sensorineural hearing loss, or SNHL) has been identified by a group of Japanese researchers, who successfully replicated the condition using a transgenic mouse.
Researchers from the Toronto Western Research Institute noted a higher prevalence of arthritis and arthritis-attributable activity limitations (AAL) in the U.S. versus the Canadian population. The authors attribute the higher prevalence of arthritis and AAL to a greater level of obesity and physical inactivity in Americans, particularly women.
In an encouraging development, an investigational vaccine regimen has been shown to be well-tolerated and to have a modest effect in preventing HIV infection in a clinical trial involving more than 16,000 adult participants in Thailand. Following a final analysis of the trial data, the Surgeon General of the U.S. Army, the trial sponsor, announced today that the prime-boost investigational vaccine regimen was safe and 31 percent effective in preventing HIV infection.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Daniel Joseph Hayes Jr, MD Po Box 252, Bryn Mawr, PA 19010-0252 Ph: (610) 527-1185 | Daniel Joseph Hayes Jr, MD 830 Old Lancaster Rd, Suite 101, Bryn Mawr, PA 19010-3118 Ph: (610) 527-1185 |
News Archive
Cellectis bioresearch, a specialist in genome customization and a subsidiary of Cellectis, today announced the publication of a scientific study describing a novel method, based on meganuclease-driven targeted integration, for the generation of stable cell lines compatible with high throughput screening (HTS).The study demonstrated Cellectis bioresearch's technology to be faster, more reliable and efficient in deriving cell-based assays for HTS studies than classical methods.
A causative gene for a highly common type of hearing loss (sensorineural hearing loss, or SNHL) has been identified by a group of Japanese researchers, who successfully replicated the condition using a transgenic mouse.
Researchers from the Toronto Western Research Institute noted a higher prevalence of arthritis and arthritis-attributable activity limitations (AAL) in the U.S. versus the Canadian population. The authors attribute the higher prevalence of arthritis and AAL to a greater level of obesity and physical inactivity in Americans, particularly women.
In an encouraging development, an investigational vaccine regimen has been shown to be well-tolerated and to have a modest effect in preventing HIV infection in a clinical trial involving more than 16,000 adult participants in Thailand. Following a final analysis of the trial data, the Surgeon General of the U.S. Army, the trial sponsor, announced today that the prime-boost investigational vaccine regimen was safe and 31 percent effective in preventing HIV infection.
› Verified 7 days ago
Richard Ing, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 830 Old Lancaster Rd, Suite 306 Mob North, Bryn Mawr, PA 19010 Phone: 484-592-3000 Fax: 484-592-3009 | |
Dr. Richard Brannon Claytor, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 135 S Bryn Mawr Ave Ste 300, Bryn Mawr, PA 19010 Phone: 610-527-4833 Fax: 610-527-7403 | |
Dr. Ashlee Anne Rice, Surgery Medicare: Medicare Enrolled Practice Location: 101 S Bryn Mawr Ave, Bryn Mawr, PA 19010 Phone: 484-222-6200 | |
Dr. Robert Barrett Noone Sr., M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 888 Glenbrook Ave, Bryn Mawr, PA 19010 Phone: 610-527-4833 Fax: 610-527-3568 | |
Jennifer L. Denne, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 830 Old Lancaster Rd, Suite 306 Mob North, Bryn Mawr, PA 19010 Phone: 484-592-3000 Fax: 484-592-3009 | |
Dr. Lina Marie Sizer, D.O Surgery Medicare: Accepting Medicare Assignments Practice Location: 101 S Bryn Mawr Ave Ste 201, Bryn Mawr, PA 19010 Phone: 610-520-0700 Fax: 610-520-0744 |